Vanessa Kiyomi Ota
Vanessa Kiyomi Ota
Department of Morphology and Genetics
Dirección de correo verificada de
Citado por
Citado por
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ...
Nature 604 (7906), 502-508, 2022
Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis
C Noto, VK Ota, ES Gouvea, LB Rizzo, LMN Spindola, PHS Honda, ...
International Journal of Neuropsychopharmacology 18 (4), pyu042, 2015
Early life adversity, genomic plasticity, and psychopathology
G Turecki, VK Ota, SI Belangero, A Jackowski, J Kaufman
The Lancet Psychiatry 1 (6), 461-466, 2014
High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
C Noto, M Maes, VK Ota, AL Teixeira, RA Bressan, A Gadelha, E Brietzke
The World Journal of Biological Psychiatry 16 (6), 422-429, 2015
Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis
MN Noto, M Maes, SOV Nunes, VK Ota, AC Rossaneis, WA Verri Jr, ...
European Neuropsychopharmacology 29 (3), 416-431, 2019
Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone
C Noto, VK Ota, A Gadelha, MN Noto, DS Barbosa, KL Bonifácio, ...
Journal of psychiatric research 68, 210-216, 2015
Effects of depression on the cytokine profile in drug naive first-episode psychosis
C Noto, VK Ota, ML Santoro, BB Ortiz, LB Rizzo, CH Higuchi, Q Cordeiro, ...
Schizophrenia research 164 (1-3), 53-58, 2015
Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic naïve first episode psychosis
C Noto, VK Ota, ML Santoro, ES Gouvea, PN Silva, LM Spindola, ...
Molecular neurobiology 53 (8), 5701-5709, 2016
Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia
A Zugman, A Gadelha, I Assunção, J Sato, VK Ota, DL Rocha, JJ Mari, ...
Schizophrenia research 148 (1-3), 81-86, 2013
Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia
E Asevedo, LB Rizzo, A Gadelha, RB Mansur, VK Ota, AA Berberian, ...
Physiology & behavior 129, 194-198, 2014
Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
ML Santoro, V Ota, S de Jong, C Noto, LM Spindola, F Talarico, E Gouvea, ...
Translational psychiatry 8 (1), 174, 2018
Implication of LRRC4C and DPP6 in neurodevelopmental disorders
G Maussion, C Cruceanu, JA Rosenfeld, SC Bell, F Jollant, J Szatkiewicz, ...
American Journal of Medical Genetics Part A 173 (2), 395-406, 2017
DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs
VK Ota, LN Spíndola, A Gadelha, AF dos Santos Filho, ML Santoro, ...
Schizophrenia research 142 (1-3), 206-208, 2012
Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis
FF Brinholi, C Noto, M Maes, KL Bonifácio, E Brietzke, VK Ota, A Gadelha, ...
Schizophrenia research 166 (1-3), 225-230, 2015
Changes in gene expression and methylation in the blood of patients with first-episode psychosis
VK Ota, C Noto, A Gadelha, ML Santoro, LM Spindola, ES Gouvea, ...
Schizophrenia research 159 (2-3), 358-364, 2014
Vascular loops in the anterior inferior cerebellar artery, as identified by magnetic resonance imaging, and their relationship with otologic symptoms
L Abreu Junior, CH Kuniyoshi, AB Wolosker, ML Borri, A Antunes, ...
Radiologia Brasileira 49, 300-304, 2016
Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls
CT Matsuzaka, D Christofolini, VK Ota, A Gadelha, AA Berberian, C Noto, ...
Brazilian Journal of Psychiatry 39, 302-308, 2017
Accessing gene expression in treatment-resistant schizophrenia
PN Moretti, VK Ota, ES Gouvea, M Pedrini, ML Santoro, F Talarico, ...
Molecular neurobiology 55, 7000-7008, 2018
A molecular model for neurodevelopmental disorders
CO Gigek, ES Chen, VK Ota, G Maussion, H Peng, K Vaillancourt, ...
Translational Psychiatry 5 (5), e565-e565, 2015
A systematic review on the effects of social discrimination on telomere length
BM Coimbra, CM Carvalho, VK Ota, T Vieira-Fonseca, A Bugiga, AF Mello, ...
Psychoneuroendocrinology 120, 104766, 2020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20